PTC Therapeutics | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 167.36M 167.35M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
Amgen USD 538M 33.04B 2025-06
Biogen USD 146.6M 146.5M 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Cytokinetics USD 119.6M 119.48M 2025-06
Daiichi Sankyo JPY 1.85B 48.15B 2025-06
Gilead Sciences USD 1.24B 3M 2025-06
Incyte USD 194.12M 193.93M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
Ironwood Pharmaceuticals USD 160K 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 5.68B 5.2B 2025-06
PTC Therapeutics USD 79.38M 79.3M 2025-06
Roche Holding CHF 107M 0 2024-06
Sarepta Therapeutics USD 97.71M 97.7M 2025-06
TG Therapeutics USD 158.02M 157.87M 2025-06
Ultragenyx Pharmaceutical USD 96.35M 2.45M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06
Xencor USD 71.3M 70.58M 2025-06


PTC Therapeutics Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.